-
Register
- User - $30
This presentation will review the increasing prevalence of syphilis, including which populations of patients should be tested for this infection. The syphilis testing cascade will be discussed, including guidance on how to ensure that an active infection has been completely treated and how often patients need follow-up and tests of reinfection. The current penicillin shortage will be discussed when the most appropriate, evidenced-based treatment
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.0 Contact Hours; 0.50 are Pharmacology
This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid from 1/1/2026 to 12/31/2026. PAs should only claim credit commensurate with the extent of their participation.
CE Expiration Date: December 31, 2026
$30
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
1. Identify current epidemiology at national, regional and state levels
2. Order the appropriate initial syphilis testing cascade and appropriate follow-up labs for positive persons
3. Prescribe evidenced based antimicrobial therapy, including regimens for pregnant persons and persons with antibiotic allergies
Alison O. Marshall, PhD, FNP-C, RN
Faculty, Sylvie Ratelle STD/HIV Prevention Center of New England
Clinical Instructor, Boston College Connell School of Nursing
Alison Marshall is a PhD prepared, Family Nurse Practitioner (FNP). She is an Assistant Professor of the Practice at Boston College School of Nursing, a Family Nurse Practitioner at the South Boston Community Health Center and Faculty at the STD/HIV Prevention Center of New England. Her research is focused on vulvar and vaginal health, vaginitis and sexually transmitted infections. Her clinical expertise is in the diagnosis, treatment and prevention of vaginitis and sexually transmitted infections. She lives in Boston with her family but will always remain loyal to her native Denver sports teams
CE/CME INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.0 contact hours, of which 0.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 1/1/2026 to 12/31/2026 . PAs should only claim credit commensurate with the extent of their participation
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
DISCLOSURES
Faculty
Contributing faculty, Alison Marshall, PhD-C, FNP-C, RN has disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
